OA treatment was able to effectively reduce BIRC5 expression in lung cancer [83], ovarian cell carcinoma [75, 84], and leukaemia [76] as well as XIAP expression in hepatocellular carcinoma [85]. The gene discussed is XIAP; the disease is lung cancer.